Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$2.22B |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$372M |
| 3 |
Danaher
DHR
|
+$293M |
| 4 |
Linde
LIN
|
+$281M |
| 5 |
Carlyle Group
CG
|
+$268M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$926M |
| 2 |
iShares Russell 1000 ETF
IWB
|
+$770M |
| 3 |
iShares Bitcoin Trust
IBIT
|
+$649M |
| 4 |
Meta Platforms (Facebook)
META
|
+$641M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$462M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 52.07% |
| 2 | Financials | 9% |
| 3 | Technology | 7.77% |
| 4 | Healthcare | 6.87% |
| 5 | Industrials | 5.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5051
CALL
Rigetti Computing Warrants
RGTIW
$157M
| $261K | ﹤0.01% |
94,900
| – | – |
|
|
VTYX
5052
DELISTED
Ventyx Biosciences
VTYX
| $260K | ﹤0.01% |
226,310
-1,055,319
| -82% | -$1.81M |
|
5053
GrafTech
EAF
$194M
| $259K | ﹤0.01% |
29,599
-128,300
| -81% | -$1.67M |
|
5054
PUT
Nutrien
NTR
$34.9B
| $258K | ﹤0.01% |
5,200
-57,300
| -92% | -$2.93M |
|
5055
Milestone Pharmaceuticals
MIST
$148M
| $258K | ﹤0.01% |
322,082
-2,381,177
| -88% | -$4.73M |
|
5056
Nuveen Multi-Asset Income Fund
NMAI
$480M
| $257K | ﹤0.01% |
21,409
| – | – |
|
|
THR
5057
DELISTED
Thermon Group Holdings
THR
| $257K | ﹤0.01% |
+9,233
| New | +$267K |
|
5058
PUT
Enbridge
ENB
$109B
| $257K | ﹤0.01% |
5,800
-432,400
| -99% | -$18.8M |
|
|
GRFS
5059
CALL
Grifois
GRFS
$5.32B
| $256K | ﹤0.01% |
36,000
-114,000
| -76% | -$860K |
|
|
EXAS
5060
PUT
DELISTED
Exact Sciences
EXAS
| $255K | ﹤0.01% |
5,900
-24,000
| -80% | -$1.22M |
|
5061
Playboy Inc
PLBY
$144M
| $254K | ﹤0.01% |
230,687
+38,542
| +20% | +$60.2K |
|
5062
OneSpaWorld
OSW
$2.66B
| $254K | ﹤0.01% |
15,107
-267,690
| -95% | -$5.21M |
|
5063
Farmers & Merchants Bancorp
FMAO
$467M
| $253K | ﹤0.01% |
+10,597
| New | +$272K |
|
|
LAND
5064
Gladstone Land Corp
LAND
$383M
| $253K | ﹤0.01% |
24,079
-164,941
| -87% | -$1.81M |
|
5065
PUT
Church & Dwight Co
CHD
$24.3B
| $253K | ﹤0.01% |
2,300
-142,500
| -98% | -$15.3M |
|
|
NML
5066
Neuberger Energy Infrastructure and Income Fund Inc
NML
$592M
| $253K | ﹤0.01% |
+28,128
| New | +$253K |
|
|
ISD
5067
PGIM High Yield Bond Fund
ISD
$411M
| $253K | ﹤0.01% |
+17,724
| New | +$249K |
|
|
BASE
5068
DELISTED
Couchbase
BASE
| $252K | ﹤0.01% |
16,016
+3,545
| +28% | +$58.8K |
|
5069
Metagenomi Therapeutics
MGX
$45.7M
| $252K | ﹤0.01% |
185,108
+170,699
| +1,185% | +$407K |
|
5070
Medifast
MED
$136M
| $251K | ﹤0.01% |
18,645
-25,451
| -58% | -$382K |
|
5071
PUT
Altimmune
ALT
$630M
| $250K | ﹤0.01% |
+50,000
| New | +$317K |
|
5072
Schwab 1000 Index ETF
SCHK
$5.89B
| $250K | ﹤0.01% |
+9,279
| New | +$264K |
|
5073
Fate Therapeutics
FATE
$304M
| $249K | ﹤0.01% |
314,877
-98,315
| -24% | -$120K |
|
|
OPLN
5074
Openlane
OPLN
$4.33B
| $249K | ﹤0.01% |
12,902
-165,346
| -93% | -$3.41M |
|
5075
Immatics
IMTX
$1.28B
| $249K | ﹤0.01% |
55,127
-101,559
| -65% | -$530K |
|
Similar funds
Israel Englander's Q1 2025 Portfolio in Review
As of Q1 2025, Israel Englander held 6,639 positions worth $188B, down 8.2% from $205B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Israel Englander withdrew a net $10.2B in Q1 2025, closing 852 positions and reducing 2,261 holdings. Its most notable exit was Verizon, an estimated $263M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 52% of assets, up from 50% a quarter earlier, followed by Financials and Technology.
Against the trend, Israel Englander opened a new position in Blackrock worth $215M.
- Israel Englander's largest Q1 2025 buy was Blackrock: 227,394 shares worth $215M.
- Israel Englander added most to iShares Core S&P 500 ETF in Q1 2025, an estimated $2.22B increase.
- Israel Englander's biggest Q1 2025 reduction was Broadcom, cutting an estimated $926M.
- Israel Englander fully exited Verizon in Q1 2025, selling an estimated $263M.
- Israel Englander's ten largest holdings make up 16% of its $188B portfolio in Q1 2025.
- Israel Englander opened 739 new positions and closed 852 in Q1 2025.
- Israel Englander's portfolio value fell 8.2% quarter-over-quarter to $188B.
Based on Millennium Management's 13F filing for Q1 2025, filed 15 May 2025.